Fairfield, Bush & Co. - investment advisor, registered investment advisor, investment advisor search  HomeAbout UsServicesContact Us  Fairfield, Bush & Co.    Fairfield, Bush & Co. has provided discretionary wealth management services to high net worth individuals and Institutions since 1973, throughout the U.S.Using a disciplined, active approach, we manage individual client portfolios to preserve and enhance the purchasing power of capital.     Fairfield, Bush & Co. offers domestic and international common stock portfolios, along with active fixed income management programs. Given our capabilities within both the equity and fixed income markets, clients who prefer to structure their portfolios in a balanced (both stocks and bonds) manner can be easily accommodated.   Investments    Advisory    Our Firm      Client portfolios are managed to preserve and enhance the purchasing power of capital over stock market cycles. Our goal is to protect capital during negative markets and to increase capital in real terms and after taxes during favorable markets. Attempting to outperform the markets during periods of overvaluation can lead to excessive investment risks and is contrary to our basic philosophy.           Strategy         Contacts  Fairfield Bush © 2017  |  All Rights Reserved     Stay Connected    265 Church Street, Suite 503, New Haven, CT 06510 US              (203) 777-5900            contact@fairfieldbush.com    HomeAbout UsServicesContact UsCharles KrauseJonathan James BushHuntington KelleyAlexander R. CookeMary MilmanChristopher GetmanErik PearsonCarol D'AmbrosiaLynn GamerdingerPenney Detchon  View on Mobile

Fairfield Bush & Co                                                                                                      - New Canaan                                        , CT         - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



CT



New Canaan



Investment Advice



Investment Counselors



                            Fairfield Bush & Co
                                    



 





















F 


Fairfield Bush & Co                                                                                                     
CLAIM THIS BUSINESS



65 LOCUST AVE STE 200 NEW CANAAN, CT 06840
Get Directions



(203) 972-0404
www.fairfieldbush.com                                                                                   





Business Info



 Founded 1973
 Incorporated 
 Annual Revenue $2,500,000.00
 Employee Count 8
 Industries Investment Counselors
 Contacts Charles A Krause                                                                                                        







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


Fairfield Bush & Co                                                                                                      was founded in 1973, and is located at 65 Locust Ave Ste 200 in New Canaan. Additional information is available at www.fairfieldbush.com                                                                                    or by contacting Charles A Krause                                                                                                         at (203) 972-0404. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







F

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.














﻿
































Roble Belko & Company Inc Has $380,000 Position in Biogen Inc. (BIIB) - Markets Daily













































 
























 




 





















Daily Ratings & News for Biogen Inc.
        	Complete the form below to receive the latest headlines and analysts' recommendationsfor Biogen Inc. with our free daily email newsletter:



 





Follow @TheMarketsDaily


The Markets Daily









Recent Posts

Costco Wholesale Corporation (COST) Position Cut by Bartlett & Co. LLC
LS Investment Advisors LLC Has $825,000 Stake in ManpowerGroup (MAN)
Coca-Cola Company (The) (KO) Stake Boosted by North American Management Corp
NN Investment Partners Holdings N.V. Boosts Position in Mueller Industries, Inc. (NYSE:MLI)
Creative Planning Raises Stake in Capital One Financial Corporation (COF)
Credit Suisse AG Has $5.29 Million Position in NutriSystem Inc (NASDAQ:NTRI)
Metropolitan Life Insurance Co. NY Has $1,620,000 Stake in Community Bank System, Inc. (NYSE:CBU)
Tetra Tech, Inc. (TTEK) Shares Sold by Metropolitan Life Insurance Co. NY
Metropolitan Life Insurance Co. NY Sells 2,210,000 Shares of Electronics for Imaging, Inc. (EFII)
State Street Corp Raises Stake in athenahealth, Inc. (NASDAQ:ATHN)
Allegiant Travel Company (NASDAQ:ALGT) Shares Bought by State Street Corp
Amalgamated Bank Cuts Position in Plexus Corp. (PLXS)
New York Times Company (The) (NYSE:NYT) Shares Bought by Schwab Charles Investment Management Inc.
U S Global Investors Inc Acquires 600 Shares of Corning Incorporated (NYSE:GLW)
Roble Belko & Company Inc Has $380,000 Position in Biogen Inc. (BIIB)
207,848 Shares in Adobe Systems Incorporated (NASDAQ:ADBE) Acquired by NorthCoast Asset Management LLC
BerganKDV Wealth Management LLC Increases Stake in Procter & Gamble Company (The) (PG)
Procter & Gamble Company (The) (PG) Shares Sold by V Wealth Management LLC
Oregon Public Employees Retirement Fund Has $3,705,000 Position in Regions Financial Corporation (RF)
CENTRAL TRUST Co Maintains Position in Hershey Company (The) (HSY)




 


Roble Belko & Company Inc Has $380,000 Position in Biogen Inc. (BIIB)

					Posted by Mitch Edgeman on Jul 23rd, 2017 // No Comments 




Roble Belko & Company Inc cut its stake in shares of  Biogen Inc. (NASDAQ:BIIB) by 8.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 1,388 shares of the biotechnology company’s stock after selling 130 shares during the period. Roble Belko & Company Inc’s holdings in Biogen were worth $380,000 as of its most recent filing with the SEC. 
Several other large investors also recently added to or reduced their stakes in the stock. Crestwood Advisors Group LLC bought a new stake in  Biogen during the first quarter valued at $106,000.  Winfield Associates Inc. raised its stake in  Biogen by 16.8% in the first quarter. Winfield Associates Inc. now owns 467 shares of the biotechnology company’s stock valued at $128,000 after buying an additional 67 shares in the last quarter.  Rational Advisors LLC raised its stake in  Biogen by 14.3% in the first quarter. Rational Advisors LLC now owns 593 shares of the biotechnology company’s stock valued at $162,000 after buying an additional 74 shares in the last quarter.  Stelac Advisory Services LLC bought a new stake in  Biogen during the first quarter valued at $164,000.  Finally, Cohen Capital Management Inc. bought a new stake in  Biogen during the first quarter valued at $178,000. Institutional investors own  87.47% of the company’s stock. 


 Get Biogen Inc. alerts:



Shares of Biogen Inc. (NASDAQ BIIB) opened at 282.92 on Friday. The company has a 50 day moving average of $269.15 and a 200-day moving average of $273.86. Biogen Inc. has a 52-week low of $244.28 and a 52-week high of $307.76. The company has a market cap of $60.01 billion, a PE ratio of 17.72 and a beta of 0.78. 




Biogen (NASDAQ:BIIB) last released its earnings results on Tuesday, April 25th. The biotechnology company reported $5.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.23. The business had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.73 billion. Biogen had a net margin of 30.17% and a return on equity of 38.17%. Biogen’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.79 earnings per share.  Analysts forecast that  Biogen Inc. will post $20.44 EPS for the current fiscal year. 
ILLEGAL ACTIVITY NOTICE: This story was first  posted by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.themarketsdaily.com/2017/07/23/roble-belko-company-inc-has-380000-position-in-biogen-inc-biib.html. 
Several equities research analysts have recently weighed in on the company. UBS AG upgraded Biogen from a “sell” rating to a “neutral” rating and upped their price objective for the company from $262.00 to $270.00 in a research note on Monday, June 19th. Vetr upgraded Biogen from a “buy” rating to a “strong-buy” rating and set a $306.48 price target on the stock in a research report on Wednesday, July 12th. BMO Capital Markets  restated a “hold” rating and set a $318.00 price target on shares of Biogen in a research report on Tuesday, July 18th. Jefferies Group LLC  restated a “hold” rating and set a $310.00 price target on shares of Biogen in a research report on Tuesday, July 11th. Finally, William Blair  restated an “outperform” rating on shares of Biogen in a research report on Monday, June 26th. Thirteen equities research analysts have rated the stock with a hold rating, fourteen have assigned  a buy rating and two have given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $325.48.
In related news, VP Paul J. Clancy sold 9,892 shares of the business’s stock in a transaction on Tuesday, April 25th. The shares were sold at an average price of $290.00, for a total value of $2,868,680.00. Following the transaction, the vice president now owns 10,813 shares in the company, valued at $3,135,770. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Alexander J. Denner bought 73,858 shares of the company’s stock in a transaction that occurred on Thursday, April 27th. The stock was purchased at an average price of $278.50 per share, for a total transaction of $20,569,453.00. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 18,734 shares of company stock worth $5,357,550. 0.32% of the stock is owned by company insiders. 
About Biogen
Biogen Inc is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA).
Want to see what other hedge funds are holding BIIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Biogen Inc. (NASDAQ:BIIB).







Receive News & Ratings for Biogen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biogen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 





























Latest News






Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website


























































About Us    Fairfield, Bush & Co.    Jonathan Bush        ManagementClient portfolios are managed to preserve and enhance the purchasing power of capital over stock market cycles. Our goal is to protect capital during negative markets and to increase capital in real terms and after taxes during favorable markets. Attempting to outperform the markets during periods of overvaluation can lead to excessive investment risks and is contrary to our basic philosophy. While Fairfield, Bush & Co. does not employ market-timing strategies, we do use dollar-cost-averaging when initiating new stock positions. We also utilize a sell discipline based on excess market valuation in relation to a company’s sales, to reduce the price risk in stocks having gains. Our advice is strictly independent and objective, with no conflict of interest with our clients. We do not function as a broker, dealer or underwriter of securities. Advisory fees are our sole compensation.  Philosophy    Huntington Kelley    Our Staff    CommunicationClient communication is an integral part of a good, long-term client relationship. Therefore, we encourage an active dialogue with our clients in an effort to facilitate a better understanding of our investment strategy and to assist in periodically reassessing the appropriateness of a clients investment objectives. In addition, each client is provided with a quarterly investment summary which includes comprehensive and historical information on a portfolios valuation, performance data, and a written summary of our investment outlook. We try to minimize the problems often associated with large firms by making ourselves constantly available to our clients, either over the telephone, via e-mail, or in face-to-face meetings.          Our Strength    Manage assets based on each client's unique profile. Identify the best managed companies offering long-term growth.Monitor markets to find undervalued opportunities.   Mary Milman  Charles Krause      Alexander Cooke    HomeAbout UsServicesContact Us    265 Church Street, Suite 503, New Haven, CT 06510 US              (203) 777-5900            contact@fairfieldbush.com    Fairfield Bush © 2017  |  All Rights Reserved     HomeAbout UsServicesContact UsCharles KrauseJonathan James BushHuntington KelleyAlexander R. CookeMary MilmanChristopher GetmanErik PearsonCarol D'AmbrosiaLynn GamerdingerPenney Detchon   Contacts  Stay Connected    View on Mobile﻿






























Barber Financial Group Inc. Has $617,000 Position in Caterpillar, Inc. (CAT) - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Caterpillar Inc.

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Caterpillar Inc. with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

643 Shares in Amazon.com, Inc. (NASDAQ:AMZN) Acquired by Virtu Financial LLC
Mastercard Incorporated (NYSE:MA) Stake Lowered by Fairfield Bush & CO.
Independence Realty Trust Inc (IRT) Position Increased by American International Group Inc.
American International Group Inc. Has $323,000 Position in LGI Homes, Inc. (LGIH)
Quorum Health Corp (NYSE:QHC) Position Cut by Bank of New York Mellon Corp
Thermo Fisher Scientific Inc (TMO) Stake Maintained by Steinberg Global Asset Management
Barber Financial Group Inc. Has $617,000 Position in Caterpillar, Inc. (CAT)
Buffington Mohr McNeal Boosts Stake in United Technologies Corporation (NYSE:UTX)
American International Group Inc. Has $318,000 Stake in Amphastar Pharmaceuticals, Inc. (AMPH)
United Technologies Corporation (NYSE:UTX) Stake Reduced by US Bancorp DE
American International Group Inc. Acquires 595 Shares of CSW Industrials, Inc. (CSWI)
PayPal Holdings Sees Unusually Large Options Volume (PYPL)
Philip Morris International Inc (NYSE:PM) Shares Bought by MCF Advisors LLC
MarineMax, Inc. (HZO) Stake Reduced by American International Group Inc.
Evolution Petroleum Corp (EPM) Shares Bought by Prudential Financial Inc.
Dai Ichi Life Insurance Company Ltd Has $4.37 Million Position in The Kraft Heinz Company (KHC)
Prudential Financial Inc. Buys Shares of 7,141 Qiagen N.V. (QGEN)
NextEra Energy, Inc. (NEE) Shares Bought by Donaldson Capital Management LLC
KBC Group NV Boosts Position in General Mills, Inc. (GIS)
Fifth Street Asset Management Inc. (FSAM) Stake Lowered by JPMorgan Chase & Co.







Barber Financial Group Inc. Has $617,000 Position in Caterpillar, Inc. (CAT)


					Posted by Oliver Carreras on Jul 22nd, 2017 // No Comments




Barber Financial Group Inc. lowered its stake in shares of  Caterpillar, Inc. (NYSE:CAT) by 0.3% during the first quarter, according to its most recent filing with the SEC. The fund owned 6,650 shares of the industrial products company’s stock after selling 19 shares during the period. Barber Financial Group Inc.’s holdings in Caterpillar were worth $617,000 as of its most recent SEC filing. 
Other large investors also recently made changes to their positions in the company. Howe & Rusling Inc. boosted its stake in shares of  Caterpillar by 52.0% in the first quarter. Howe & Rusling Inc. now owns 1,087 shares of the industrial products company’s stock valued at $101,000 after buying an additional 372 shares in the last quarter.  First Personal Financial Services boosted its stake in shares of  Caterpillar by 167.4% in the first quarter. First Personal Financial Services now owns 1,198 shares of the industrial products company’s stock valued at $111,000 after buying an additional 750 shares in the last quarter.  Financial Architects Inc boosted its stake in shares of  Caterpillar by 5.7% in the first quarter. Financial Architects Inc now owns 1,215 shares of the industrial products company’s stock valued at $113,000 after buying an additional 65 shares in the last quarter.  Ledyard National Bank boosted its stake in shares of  Caterpillar by 145.7% in the first quarter. Ledyard National Bank now owns 1,425 shares of the industrial products company’s stock valued at $132,000 after buying an additional 845 shares in the last quarter.  Finally, Integrated Investment Consultants LLC boosted its stake in shares of  Caterpillar by 17.1% in the first quarter. Integrated Investment Consultants LLC now owns 1,710 shares of the industrial products company’s stock valued at $159,000 after buying an additional 250 shares in the last quarter. Hedge funds and other institutional investors own  70.70% of the company’s stock. 


 Get Caterpillar Inc. alerts:



Shares of Caterpillar, Inc. (NYSE CAT) opened at 106.59 on Friday. The stock’s market cap is $62.79 billion. The stock’s 50 day moving average price is $106.32 and its 200-day moving average price is $99.06. Caterpillar, Inc. has a 1-year low of $78.34 and a 1-year high of $110.00.  Caterpillar also was the recipient of unusually large options trading on Thursday. Investors  bought  14,052 put options on the company. This represents an increase of approximately 107% compared to the typical volume of 6,777 put options.





Caterpillar (NYSE:CAT) last announced its earnings results on Tuesday, April 25th. The industrial products company reported $1.28 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.66. The firm had revenue of $9.82 billion during the quarter, compared to analysts’ expectations of $9.27 billion. Caterpillar had a positive return on equity of 16.46% and a negative net margin of 0.38%. The company’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 EPS.  On average, equities research analysts forecast that  Caterpillar, Inc. will post $4.27 earnings per share for the current year. 
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, August 19th. Investors of record on Thursday, July 20th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, July 18th. This represents a $3.12 dividend on an annualized basis and a yield of 2.93%. This is a boost from Caterpillar’s previous quarterly dividend of $0.77. Caterpillar’s payout ratio is presently -1,155.51%. 
TRADEMARK VIOLATION WARNING: “Barber Financial Group Inc. Has $617,000 Position in Caterpillar, Inc. (CAT)” was first  reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/22/barber-financial-group-inc-has-617000-position-in-caterpillar-inc-cat.html. 
Several equities research analysts have recently weighed in on CAT shares. Zacks Investment Research upgraded Caterpillar from a “hold” rating to a “buy” rating and set a $107.00 price target on the stock in a research report on Monday, April 10th. Deutsche Bank AG decreased their price target on Caterpillar from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Thursday, April 6th. Raymond James Financial, Inc. upgraded Caterpillar to a “buy” rating and set a $55.00 price target on the stock in a research report on Thursday, April 27th. Vetr upgraded Caterpillar from a “sell” rating to a “buy” rating and set a $107.75 price target on the stock in a research report on Monday, May 8th. Finally, Bank of America Corporation upgraded Caterpillar from a “neutral” rating to a “buy” rating and upped their price target for the company from $105.00 to $120.00 in a research report on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, eleven have assigned  a buy rating and one  has issued  a strong buy rating to the stock. The company  has an average rating of “Hold” and an average target price of $97.72.
Caterpillar Company Profile

Want to see what other hedge funds are holding CAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Caterpillar, Inc. (NYSE:CAT).







Receive News & Ratings for Caterpillar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caterpillar Inc. and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 
























































 









CA Inc. (NASDAQ:CA) Stake Maintained by Mandatum Life Insurance Co Ltd | Daily Political











































































Home
About/Contact
Columnists
Privacy Policy
























Headlines
Politics
Nation
World
Issues
Economy
Finance




















CA Inc. - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for CA Inc. with our FREE daily email newsletter:



 






Follow DailyPolitical

 
 










Latest News



Aberdeen Asset Management plc (LON:ADN) Lifted to Buy at HSBC Holdings plc					

Mandatum Life Insurance Co Ltd Sells 1,411 Shares of McCormick & Company, Incorporated (NYSE:MKC)					

CA Inc. (NASDAQ:CA) Stake Maintained by Mandatum Life Insurance Co Ltd					

Premier Oil PLC (LON:PMO) Price Target Raised to GBX 72					

Mandatum Life Insurance Co Ltd Has $3,117,000 Position in Monster Beverage Corporation (NASDAQ:MNST)					

Williams-Sonoma, Inc. (NYSE:WSM) Position Held by Mandatum Life Insurance Co Ltd					

Paychex, Inc. (PAYX) Shares Sold by TNB Financial					

TNB Financial Sells 355 Shares of Deere & Company (DE)					

TNB Financial Continues to Hold Stake in L-3 Communications Holdings, Inc. (LLL)					

Capital Trust, Inc. (BXMT) Position Held by TNB Financial					

Time Warner Inc. (TWX) Position Raised by Pier 88 Investment Partners LLC					

Pier 88 Investment Partners LLC Purchases 2,900 Shares of Akamai Technologies, Inc. (AKAM)					

Canal Capital Management LLC Has $356,000 Stake in BB&T Corporation (BBT)					

Cwm LLC Purchases New Position in Allscripts Healthcare Solutions, Inc. (MDRX)					

TiVo Corporation (TIVO) Shares Sold by Cwm LLC					

Cwm LLC Has $1.84 Million Stake in Grifols, S.A. (NASDAQ:GRFS)					

Cwm LLC Decreases Stake in Caesarstone Ltd. (NASDAQ:CSTE)					

Cwm LLC Acquires 7,202 Shares of Range Resources Corporation (NYSE:RRC)					

Sky Investment Group LLC Has $251,000 Position in Air Products and Chemicals, Inc. (NYSE:APD)					

Dixon Hubard Feinour & Brown Inc. VA Has $233,000 Stake in Reynolds American Inc (NYSE:RAI)					





 





						CA Inc. (NASDAQ:CA) Stake Maintained by Mandatum Life Insurance Co Ltd					

						 July 18th, 2017  - 0 comments - Filed Under -
 by Jeff Wilder 


							Filed Under: Finance - SEC Filing Articles 







Tweet










Mandatum Life Insurance Co Ltd continued to hold its position in shares of  CA Inc. (NASDAQ:CA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor  owned 97,004 shares of the technology company’s stock at the end of the second quarter. Mandatum Life Insurance Co Ltd’s holdings in CA were worth $3,344,000 at the end of the most recent reporting period. 
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Country Club Trust Company n.a. boosted its stake in  CA by 1.8% in the first quarter. Country Club Trust Company n.a. now owns 300,164 shares of the technology company’s stock worth $9,521,000 after buying an additional 5,361 shares during the period.  First National Bank of Mount Dora Trust Investment Services boosted its stake in shares of  CA by 18.2% in the first quarter. First National Bank of Mount Dora Trust Investment Services now owns 62,163 shares of the technology company’s stock valued at $1,972,000 after buying an additional 9,575 shares during the last quarter.  Creative Planning boosted its stake in shares of  CA by 43.9% in the first quarter. Creative Planning now owns 5,989 shares of the technology company’s stock valued at $190,000 after buying an additional 1,828 shares during the last quarter.  Hefty Wealth Partners boosted its stake in shares of  CA by 5,080.4% in the first quarter. Hefty Wealth Partners now owns 5,284 shares of the technology company’s stock valued at $167,000 after buying an additional 5,182 shares during the last quarter.  Finally, Manning & Napier Advisors LLC boosted its stake in shares of  CA by 9.6% in the first quarter. Manning & Napier Advisors LLC now owns 81,859 shares of the technology company’s stock valued at $2,595,000 after buying an additional 7,188 shares during the last quarter. 70.62% of the stock is owned by institutional investors. 
CA Inc. (CA) traded down 1.45% during midday trading on Tuesday, reaching $34.00. The company’s stock had a trading volume of 396,012 shares. The company has a 50 day moving average of $32.41 and a 200-day moving average of $32.25. The company has a market capitalization of $14.21 billion, a P/E ratio of 18.38 and a beta of 0.87. CA Inc. has a 1-year low of $30.01 and a 1-year high of $36.54. 




CA (NASDAQ:CA) last issued its quarterly earnings data on Thursday, May 11th. The technology company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.05. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $996.59 million. CA had a return on equity of 17.15% and a net margin of 19.20%. The firm’s quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.60 earnings per share.  Equities research analysts anticipate that  CA Inc. will post $2.38 earnings per share for the current fiscal year. 
WARNING: “CA Inc. (NASDAQ:CA) Stake Maintained by Mandatum Life Insurance Co Ltd” was originally  published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/07/18/ca-inc-nasdaqca-stake-maintained-by-mandatum-life-insurance-co-ltd.html. 
Several analysts have issued reports on CA shares. Jefferies Group LLC  restated a “buy” rating and issued a $38.00 target price on shares of CA in a report on Wednesday, June 21st. Zacks Investment Research raised CA from a “sell” rating to a “hold” rating in a research note on Tuesday, March 28th. Oppenheimer Holdings, Inc.  reaffirmed a “market perform” rating on shares of CA in a research note on Friday, May 12th. Raymond James Financial, Inc.  reaffirmed a “market perform” rating on shares of CA in a research note on Thursday, June 22nd. Finally, Citigroup Inc.  reaffirmed a “neutral” rating and issued a $34.00 price target (up previously from $33.00) on shares of CA in a research note on Sunday, May 14th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued  a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $35.10.
In other CA news, insider Ayman Sayed sold 30,194 shares of the company’s stock in a transaction that occurred on Wednesday, June 21st. The stock was sold at an average price of $35.62, for a total transaction of $1,075,510.28. Following the sale, the insider now owns 168,455 shares in the company, valued at $6,000,367.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own  0.90% of the company’s stock. 
CA Company Profile
CA, Inc (CA) is engaged in providing software solutions enabling customers to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The Company operates through three business segments: Mainframe Solutions, Enterprise Solutions and Services.
Want to see what other hedge funds are holding CA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CA Inc. (NASDAQ:CA).






Receive News & Ratings for CA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 
















 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be deleted!




Latest News




Jeff Sessions Spoke of Resigning After Tensions Increase with Trump





President Trump’s Tweets Complicate Already Complicated Week





World Leaders Very Critical of Paris Agreement Decision by Trump





Aide to President Trump Resigns With More Expected





Scud-Class Missile Launched by North Korea














			© DailyPolitical, LLC 2009-2017. All rights reserved. 


Privacy Policy |
			About | Columnists 
			| Contact 
























































Fairfield, Bush & Co. - investment advisor, registered investment advisor, investment advisor search  HomeAbout UsServicesContact Us  Fairfield, Bush & Co.    Fairfield, Bush & Co. has provided discretionary wealth management services to high net worth individuals and Institutions since 1973, throughout the U.S.Using a disciplined, active approach, we manage individual client portfolios to preserve and enhance the purchasing power of capital.     Fairfield, Bush & Co. offers domestic and international common stock portfolios, along with active fixed income management programs. Given our capabilities within both the equity and fixed income markets, clients who prefer to structure their portfolios in a balanced (both stocks and bonds) manner can be easily accommodated.   Investments    Advisory    Our Firm      Client portfolios are managed to preserve and enhance the purchasing power of capital over stock market cycles. Our goal is to protect capital during negative markets and to increase capital in real terms and after taxes during favorable markets. Attempting to outperform the markets during periods of overvaluation can lead to excessive investment risks and is contrary to our basic philosophy.           Strategy         Contacts  Fairfield Bush © 2017  |  All Rights Reserved     Stay Connected    265 Church Street, Suite 503, New Haven, CT 06510 US              (203) 777-5900            contact@fairfieldbush.com    HomeAbout UsServicesContact UsCharles KrauseJonathan James BushHuntington KelleyAlexander R. CookeMary MilmanChristopher GetmanErik PearsonCarol D'AmbrosiaLynn GamerdingerPenney Detchon  View on Mobile












Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.


